Veeva Systems (VEEV) said Wednesday it is launching Falcon, an agentic platform to support drug development projects.
Falcon is designed to integrate with Veeva's clinical, regulatory, and safety applications to cut costs and maintain compliance for biopharma clients, the company said.
Early adopter availability is expected in November, Veeva said.
Veeva shares were 2% higher in Wednesday trading.
Price: 159.08, Change: +0.58, Percent Change: +0.37
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.